Predicting age-specific dosing of antipsychotics

H. Uchida, B. G. Pollock, R. R. Bies, D. C. Mamo

研究成果: Review article査読

41 被引用数 (Scopus)

抄録

Antipsychotic medications are the standard of care for both acute and maintenance treatment of schizophrenia, the latter requiring an indefinite treatment across a patients life span. However, dosing and tolerability of antipsychotics have been studied primarily in younger patients, and very limited data are available for age- and phase-specific dosing. This leaves the clinician with no guidance on dose adjustment as patients grow olderan issue of critical importance, especially in light of recent concerns about increased morbidity and mortality associated with antipsychotics.

本文言語English
ページ(範囲)360-362
ページ数3
ジャーナルClinical Pharmacology and Therapeutics
86
4
DOI
出版ステータスPublished - 2009 10

ASJC Scopus subject areas

  • 薬理学
  • 薬理学(医学)

フィンガープリント

「Predicting age-specific dosing of antipsychotics」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル